胆囊癌伴结肠系膜、大网膜、结肠转移漏诊1例报告
A Case Report of Missed Diagnosis of Gallbladder Carcinoma with Colonic Mesocolon, Omentum and Colon Metastasis
DOI: 10.12677/ACM.2022.12111441, PDF,   
作者: 李 哲:大理大学临床医学院,云南 大理;谭云波, 金礼权*:大理大学第一附属医院普外一科,云南 大理
关键词: 胆囊癌转移漏诊Gallbladder Cancer Metastasis Missed Diagnosis
摘要: 胆囊癌是一种胆道的恶性肿瘤,起源于胆囊黏膜,发病较隐匿。胆囊癌的早期发展通常是无症状的,也具有较高的转移扩散倾向,因此诊断较晚,预后极差,手术切除率较低,对放化疗治疗不敏感。在全球的发病率也不同,比如在发达国家中并不常见,但其在发展中国家的某些地区很常见。因此,漏诊率、误诊率也是影响胆囊癌诊治的主要问题。尽管胆囊癌发病率较低,但其死亡率较高。
Abstract: Gallbladder cancer is a malignant tumor of the biliary tract, which originates from the gallbladder mucosa and has a hidden incidence. The early development of gallbladder cancer is usually asymp-tomatic, and it also has a high tendency of metastasis and diffusion, so the diagnosis is late, the re-section rate is low and the prognosis is very poor, it is insensitive to radiotherapy and chemothera-py. The global incidence rate is also different. For example, it is not common in developed countries, but it is common in some parts of developing countries. Therefore, the rate of missed diagnosis and misdiagnosis is also the main problem affecting the diagnosis and treatment of gallbladder cancer. Although the incidence rate of gallbladder cancer is low, its mortality is high.
文章引用:李哲, 谭云波, 金礼权. 胆囊癌伴结肠系膜、大网膜、结肠转移漏诊1例报告[J]. 临床医学进展, 2022, 12(11): 9998-10002. https://doi.org/10.12677/ACM.2022.12111441

参考文献

[1] Ganeshan, D., Kambadakone, A, Nikolaidis, P., Subbiah, V., Subbiah, I.M. and Devine, C. (2021) Current Update on Gallbladder Carcinoma. Abdominal Radiology, 46, 2474-2489. [Google Scholar] [CrossRef] [PubMed]
[2] Roa, J.C., Basturk, O. and Adsay, V. (2021) Dysplasia and Car-cinoma of the Gallbladder: Pathological Evaluation, Sampling, Differential Diagnosis and Clinical Implications. Histo-pathology, 79, 2-19. [Google Scholar] [CrossRef] [PubMed]
[3] Sons, H.U., Borchard, F. and Joel, B.S. (1985) Carcinoma of the Gallblad-der: Autopsy Findings in 287 Cases and Review of the Literature. Journal of Surgical Oncology, 28, 199-206. [Google Scholar] [CrossRef] [PubMed]
[4] 窦常伟, 张成武. 腹腔镜胆囊癌根治术的临床应用体会及思考[J]. 肝胆胰外科杂志, 2020, 32(5): 270-273, 276.
[5] Peng, H., Fan, K., Zan, R., Gong, Z.J., Sun, W., Sun, Y., Wang, W., Jiang, H., Lou, J., Ni, J., Suo, T. and Zhang, X. (2021) Degradable Magnesium Implants Inhibit Gallbladder Cancer. Acta Biomaterialia, 128, 514-522. [Google Scholar] [CrossRef] [PubMed]
[6] Henson, D.E., Albores-Saavedra, J. and Code, D. (1992) Carci-noma of the Gallbladder. Histologic Types, Stage of Disease, Grade, and Survival Rates. Cancer, 70, 1493-1497, [Google Scholar] [CrossRef
[7] Nimura, Y. (2002) Extended Surgery in Bilio-Pancreatic Cancer: The Japanese Experience. Seminars in Oncology, 29, 17-22. [Google Scholar] [CrossRef
[8] Malenica, I., Donadon, M. and Lleo, A. (2020) Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift towards a Personalized Medicine. Can-cers, 12, Article No. 2190. [Google Scholar] [CrossRef] [PubMed]
[9] Ausania, F., Tsirlis, T., White, S.A., French, J.J., Jaques, B.C., Charnley, R.M. and Manas, D.M. (2013) Incidental pT2-T3 Gallbladder Cancer after a Cholecystectomy: Outcome of Staging at 3 Months Prior to a Radical Resection. HPB (Oxford), 15, 633-637. [Google Scholar] [CrossRef] [PubMed]
[10] Tange, S., Hakuta, R., Nakai, Y., Oyama, H., Noguchi, K., Ito, Y., Bae, Y., Kumasaka, T. and Yoshida, H. (2021) A Rare Case of Gallbladder Cancer with Multiple Metastases to the Colon. Clini-cal Journal of Gastroenterology, 14, 608-612. [Google Scholar] [CrossRef] [PubMed]
[11] 陈晨, 刘德春, 从龙龙, 等. 基于阳性淋巴结数的进展期胆囊癌患者生存列线图预测模型[J]. 中华肝脏外科手术学电子杂志, 2018, 7(4): 274-279.
[12] Lee, S.E., Kim, K.S., Kim, W.B., et al. (2014) Practical Guidelines for the Surgical Treatment of Gallbladder Cancer. Journal of Korean Medi-cal Science, 29, 1333-1340. [Google Scholar] [CrossRef] [PubMed]
[13] 王健东, 全志伟. 胆囊癌的综合治疗[J]. 中华消化外科杂志, 2011, 10(2): 93-95.
[14] 杨庆芬, 郭建. 胆囊癌与慢性胆囊炎的CT鉴别诊断价值[J]. 影像研究与医学应用, 2021, 5(18): 14-15.
[15] 张剑. 胆囊癌发病相关危险因素的研究进展[J]. 现代医药卫生, 2022, 38(1): 85-89.
[16] Llovet, J.M., De Baere, T., Kulik, L., Haber, P.K., Greten, T.F., Meyer, T. and Lencioni, R. (2021) Locoregional Therapies in the Era of Molecular and Immune Treatments for Hepatocellular Carcinoma. Nature Reviews Gastroenterology & Hepatology, 18, 293-313. [Google Scholar] [CrossRef] [PubMed]